Hyundai Motor, Kia to Recall 170,000 EVs in South Korea
By Kwanwoo Jun
Hyundai Motor and sibling company Kia will recall around 170,000 electric vehicles in South Korea for faulty software that could cause a power loss while driving.
South Korea's Ministry of Land, Infrastructure and Transport said in a statement Thursday that Hyundai will voluntarily recall 113,916 EVs in the country from March 18. The recall affects five of the carmaker's Ioniq and Genesis models.
Errors in software for the Integrated Control Charging Unit in the vehicles subject to the recall could make it difficult to power a low-voltage battery, meaning that the cars could stop while running, the ministry said.
Kia will also recall 56,016 units of its EV6 model in South Korea due to the same issue, the ministry added.
The ministry didn't say how many Hyundai and Kia vehicles could be affected by the issue outside of South Korea.
Hyundai Motor Group said that it doesn't yet have an official estimate on the global impact of the latest recall. Some local media outlets reported that around 600,000 EVs could be affected globally.
Write to Kwanwoo Jun at kwanwoo.jun@wsj.com
(END) Dow Jones Newswires
March 14, 2024 04:22 ET (08:22 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening in the Markets This Week
-
4 Top Dividend-Paying REIT Stock Picks
-
After Earnings, Is Netflix Stock a Buy, a Sell, or Fairly Valued?
-
P-CAPE: A Better Way for Investors to Estimate Future Returns
-
Which Stocks Have Driven the Stealth Large-Value Rally?
-
Forecasts for Q2 GDP Report Show a Healthy but Slowing Economy
-
5 Stocks to Buy as the Market Rally Broadens
-
4 Top US Travel Stock Picks
-
How Do Interest Rates Affect Stock Market Returns?
-
American Airlines Earnings: Ticket Distribution Misstep Affected Results
-
Going Into Earnings, Is Albemarle Stock a Buy, a Sell, or Fairly Valued?
-
3 Top Cybersecurity Stock Picks for Long-Term Investors
-
AbbVie Earnings: Firm Sees Strong Next-Generation Immunology Drugs Sales
-
Ford Earnings: Warranty Problems on Older Vehicles Slam Results
-
ServiceNow Earnings: Operating on a Higher Plane Within Enterprise Software